Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EphA2 as a therapeutic target for cancer

EphA2 as a therapeutic target for cancer

US Patent 7776327 · Granted Aug 17, 2010

Estimated economic value: $383,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EphA2 T-cell epitope agonists and uses therefore2023
EPHA2 t-cell epitope agonists and uses therefore2020
EphA2 T-cell epitope agonists and uses therefore2018
EphA2 T-cell epitope agonists and uses therefore2016
Anti-TSG101 antibodies and their uses for treatment of viral infections2014
EPHA2 as a therapeutic target for cancer2013
EPHA2 as a therapeutic target for cancer2013
EPHA2 as a therapeutic target for cancer2013
Methods of inhibiting HIV infectivity2013
Methods of inhibiting viral infection2012
EphA2 T-cell epitopes and uses therefor2012
Therapeutic targeting of escort proteins2011